Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
FDA Grants Breakthrough Therapy Designation to INOVIO's INO-3107 for Recurrent Respiratory Papillomatosis
INOVIO, a biotechnology firm specializing in the development and commercialization of DNA-based therapeutics for HPV-related diseases, cancer, and infectious ailments, has recently achieved a significant milestone....
ENHERTU® Secures Dual Breakthrough Therapy Designations from US Regulatory Authorities
ENHERTU® has recently been granted two additional Breakthrough Therapy Designations (BTDs) by regulatory authorities in the United States. These designations pertain to the treatment of specific groups of patients facing challenging medical circumstances...
Zai Lab's Repotrectinib Earns Breakthrough Designation in China for NTRK-Positive Tumors
Zai Lab Limited has announced the granting of Breakthrough Therapy Designation by the Center for Drug Evaluation (CDE) under the National Medical Products Administration (NMPA). This designation applies to the investigational drug repotrectinib, which is intended for the treatment of advanced solid tumors characterized by NTRK gene fusions....
HUTCHMED Achieves Breakthrough Therapy Designation for Savolitinib's Potential in Treating Gastric Cancer
HUTCHMED has announced a significant milestone in the field of gastric cancer treatment. The Center for Drug Evaluation under China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to savolitinib....
Artiva Biotherapeutics Secures FDA Nod for AlloNK® Cell Therapy alongside Rituximab in Lupus Nephritis Treatment
Artiva Biotherapeutics, a clinical-stage company with a focus on delivering highly effective, off-the-shelf allogeneic natural killer (NK) cell-based therapies, has received FDA clearance for its Investigational New Drug (IND) application concerning AlloNK® (also known as AB-101)....
Novel Compounds Combat Viruses by Disrupting Their Envelope Structures
Researchers explored seven different peptoids with the aim of targeting virus membranes rather than their proteins. This innovative approach could usher in a new era of antiviral drugs....
Jacobio Pharma Secures Breakthrough Designation for Glecirasib a Pancreatic Cancer Drug
Jacobio Pharma, a company dedicated to advancing oncology treatments, has revealed a significant development. Their internally developed KRAS G12C inhibitor, named glecirasib, has received the coveted breakthrough therapy designation (BTD) from China's Center for Drug Evaluation (CDE), a division of the National Medical Products Administration (NMPA). This designation is intended for pancreatic cancer patients with a specific KRAS G12C mutation who have not responded to standard initial treatments....
FDA Grants Extended Breakthrough Therapy Designation to NS-089/NCNP-02 for Duchenne Muscular Dystrophy
NS Pharma's recent announcement highlights the regulatory acknowledgment by the U.S. Food and Drug Administration, underscoring the significance of their investigational candidate, NS089/NCNP-02. This designation is intended for patients who have Duchenne muscular dystrophy amenable to exon 44 skipping therapy....
FDA Grants Breakthrough Therapy Designation to Renibus Therapeutics' RBT-1 for Cardiothoracic Surgery Complications
Renibus Therapeutics, Inc., a clinical-stage biopharmaceutical company specializing in the prevention and treatment of cardio-renal diseases, recently made an announcement regarding the Breakthrough Therapy designation granted to their drug candidate, RBT-1...
T2 Biosystems Receives FDA Breakthrough Device Designation for Candida Auris Detection Test T2
T2 Biosystems, Inc. is a leading company specializing in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes....
